A week of intense cycling may burn abdominal fat without major weight loss, study finds

Gilead’s ac­qui­si­tion of CymaBay Ther­a­peu­tics un­der­scores the com­pa­ny’s his­toric suc­cess in liv­er dis­eases and could bring in $1 bil­lion in peak an­nu­al sales. Gilead an­nounced

It’s a clas­sic bio­phar­ma sto­ry. In Jan­u­ary, David Khougaz­ian bumped in­to Flag­ship Pi­o­neer­ing founder Noubar Afeyan at the JP Mor­gan health­care con­fer­ence. They caught up,